Blog Detail
Pharma Strategy Blog
http://www.pharmastrategyblog.com
Where science, medicine, biotechnology, health care and social media meet.
Recent Posts
Things to be thankful for
The day before Thanksgiving, I spent a delightful afternoon here in San Diego with Mary Canady of Conprendia (@comprendia on Twitter). She runs a company specialising in Biotechnology Marketing. The beauty of meeting people like Mary on Twitter is ...
Commentary on the breast cancer controversy
After the recent furore over the breast cancer guidelines, I've been ignoring the hype and hysteria in the news and quietly waiting for some thoughtful commentary from some breast cancer experts I respect. This morning I got my wish with an email...
Hitting the blind side
This week I've been reading a fascinating book about Michael Oher's journey to the NFL. The title? The Blind Side. And then I had a thought. That's exactly what the cancer cell aims to protect it's blind side from assault. New development...
New developments in pancreatic cancer @AACR
Pancreatic cancer is a devastating disease with a generally poor prognosis, largely because it is usually detected in late stage disease where chemotherapy options generally have a limited effect. Typically response rates with gemcitabine are aroun...
Why can\'t we keep AML patients in remission?
That was the key question posed by Gail Roboz during her improvised talk at the recent Greenspan Chemotherapy Foundation meeting in New York. She was standing in for Janice Gabrilove who was unfortunately sick, but managed to put together 16 mins o...
links for 2009-11-20
FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet The U.S. Food and Drug Administration today warned consumers to use extreme care when purchasing any products over the Internet that...

